About us

RTsafe was founded in 2014 by medical physics professors with considerable experience in the field of radiation oncology, aiming to address the issue of quality assurance in radiotherapy.

RTsafe expanded rapidly and established collaborations with renowned hospitals and academic institutions thanks to the exceptional teamwork of its experienced scientists and software developers. Our customers’ confidence in our products and services make us feel proud and inspires us to keep thinking forward and constantly improve the quality of our solutions.

Helping to create a world where every radiotherapy intervention is tested on a personalized phantom before the real patient, thus contributing to the safety and effectiveness of treatment.

Vision

Helping to create a world where every radiotherapy intervention is tested on a personalized phantom before the real patient, thus contributing to the safety and effectiveness of treatment.

Our Technology

RTsafe offers dosimetry services which incorporate phantoms built from real patient anatomical data by combining proven expertise in medical physics with highly accurate 3D printing technology.

Point, 2D or 3D dosimetry can be implemented using these dosimetry phantoms. Planning CT scanning, Treatment Planning, Set-up/Immobilization, Image Guidance and Treatment delivery are applied to the RTsafe phantoms as if they are real living patients. This approach results in a true End-to-End QA testing that incorporates all links of the treatment chain.

Certifications

ISO 9001:2015 QMS

International Standard for Quality Management Systems.

ISO 13485:2016 Medical Devices

International Standard for a comprehensive Quality Management System for the design and manufacture of medical devices.

FDA 510(k) Personalized PseudoPatient™ PV

International Standard for a comprehensive Quality Management System for the design and manufacture of medical devices.

Patent

RTsafe’s vision is to make Stereotactic Radiosurgery / Radiotherapy (SRS/SRT) more efficient and accessible with patient-specific quality control procedures that enhance patient safety and empower confidence in using such challenging and advanced radiotherapy techniques. RTsafe’s complete armamentarium of solutions (personalized and generic, using 1, 2 and 3D dosimetry services) is currently offered to the whole radiotherapy community by a growing network of distributors worldwide. The patent concerns Personalized (i.e. patient-specific) Radiotherapy Treatment Verification and Quality Assurance.

Milestones

RTsafe labs in Switzerland

Establishment of new offices and labs in Lausanne in order to support its operations in Switzerland.

RTsafe expands in the US market

Setup of a new subsidiary in San Antonio, Texas.

Personalized PseudoPatient™ Receives 510(k) FDA Clearance

Our technology now has Social recognition in the US. This means that a treatment cycle can be simulated with extreme accuracy before the patient is exposed to radiation.

RTsafe wins 2019 R&D 100 Award

RTsafe’s Personalized PseudoPatient™ receives a 2019 R&D 100 Award from R&D World Magazine as one of the 100 most technologically significant products of the past year.

RTsafe owns ISO13485 Certification and PseudoPatient CE certification

RTsafe is certified with ISO13485 and the PseudoPatient CE

RTsafe expands in more than 22 countries

RTsafe succeeded in a market expansion access through distribution in more than 22 countries from Europe, Asia and Middle East.

Our Team

Evangelos drives the business strategy at RTsafe. He’s also Associate Professor of radiotherapy medical physics at the University of West Attica, Greece and a research associate at UT Health San Antonio, MD Anderson Cancer Center. His research interests are focused in addressing geometric & dosimetric challenges present in modern SRS applications. He has a PhD from University of Athens Medical School where he presented the first alternative 3D polymer gel MRI dosimeter and its introduction in radiotherapy.

Evangelos PappasFounder & Chief Scientific Officer

Georgios is responsible for the 3D digital design of the 3D printed phantom, the data analysis, the communication and the whole scientific support and guidance of the end user. He has a Diploma in Electronic & Computer Engineering, where he focused on the estimation of pharmacokinetic parameters via dynamic contrast enhancement imaging in order to annotate the perfusion of the brain tumor. During his PhD in medical school in the University of Crete, he introduced advanced MRI biomarkers in CNS diseases.

Georgios KalaitzakisChief Operations Officer/Engineer

Elisavet is responsible for supporting management, interacting with customers and vendors, handling exports and imports and maintaining financial records at RTsafe. Prior to joining RTsafe, Elisavet gained experience in management support at Kratis, Notos Associates, and Solin. Elisavet assisted in the implementation of the EU project “Minority Citizens – Equal Citizens” at Rumvader, the Organization that supports the Greek Community Foundations in Turkey, as part of her master’s program.

Elisavet MantzoglouSales Operations Coordinator

Emmanouil is responsible for product management, data analysis, and film dosimetry at RTsafe. He has a Diploma in Applied Mathematics & Physics from the National Technical University of Athens and a Master of Science in Medical Physics from the National and Kapodistrian University of Athens. His research interests focus on radiation therapy with emphasis on quality assurance in stereotactic radiosurgery, experimental and computational dosimetry using Monte Carlo simulation techniques.

Emmanouil ZorosMedical Physicist - Product Manager

Thomas is the head of MRI quality assurance lab at RTsafe. He’s also an Associate Professor of Medical Physics at the University of Crete. His research interests are focused in advanced MRI sequence design with implementations in Gel Dosimetry, Relaxometry, Diffusion/Perfusion and MRI QA and safety. A member of the board of the Hellenic Association of Physicists in Medicine for the last 20 years. He has a PhD from University of Athens Medical School utilizing advanced quantitative MRI techniques.

Thomas Maris Co-founder & Head of MRI QA lab

Kosmas Kollaros is responsible for the smooth function of RTsafe's laboratory. On a mission to manage the workflow and the quality of the products, he is focused on running quality tests on all stages of the production. Prior to taking on his role at RTsafe, Kosmas gained experience in management as the Assistant Manager at Piraeus Bank.

Kosmas KollarosLab Manager

Vasilis is responsible for 3D digital design and data analysis at RTsafe. He has a degree in Network Technology and Installation and has taken seminars in Cisco Network Academy based on Network Installations.

Vasilis ProtogerosAssistant Project Manager

Fanis is responsible for financial & accounting management along with international tax structure strategy at RTsafe. On a mission to scaling RTsafe’s growth, he is focused on improving financial performance and ensuring the ultimate implementation of the company’s business plan. He has graduated from University of Athens, Department of Mathematics, specializing in Economics.

Fanis FilisChief Financial Officer

Marianna leads RTsafe’s marketing & communication activities. In the past, she has worked for Hygeia group where she gained experience in Marketing, Event Management and Healthcare Customer Service. Marianna is currently the founder of a digital platform specialized in social events. She holds an MSc Services Management from AUEB and has a specialization in Digital Marketing.

Marianna LiondouMarketing Manager

Gareth oversees the branding, publicity and communications activities for RTsafe and is a member of the Board of Directors. Following a psychology degree from City University, London he joined ITT as a Commercial Intelligence Officer in 1979 before becoming a partner at Harvard Public Relations. He was appointed Managing Director of Harvard in 2001 and became Executive Chairman of the company's healthcare division in 2003. In 2007 he joined global business group, Libra Group, as Head of Communications.

Gareth ZundelMarketing Director

Request a quote

Testimonials

Encephalon 3D Limitless SRS - We’ve lacked the ability to evaluate a real clinical delivery of 3D dose to multiple off-axis targets sharing a single isocenter with one independent tool. But now we can! I am an impressed customer and grateful physicist, grateful to have such a comprehensive tool to evaluate our most important and critical type of treatment delivery, SRS to multiple lesions at one time. To us, this kind of 3D dose feedback is a major step forward for the world of QA.

About